60-day Federal Register Notice

Federal Register / Vol. 85, No. 109 / Friday, June 5, 2020 / Notices
period following the payment of the fee.
Section 1102.403 clarified that States
may align a one-year period with any
12-month period, which may, or may
not, be based on the calendar year. The
registration cycle is left to the
individual States to determine.
Current Action: There are no changes
being made to this regulation.
Type of Review: Extension of a
currently approved collection.
Affected Public: States; businesses or
other for-profit and not-for-profit
organizations.
Estimated Number of Respondents:
500 AMCs, 55 States.
Estimated Total Annual Burden
Hours: 500 hours.
Frequency of Response: Event
generated.
By the Appraisal Subcommittee.
James R. Park,
Executive Director.
[FR Doc. 2020–12174 Filed 6–4–20; 8:45 am]
BILLING CODE 6700–01–P

GENERAL SERVICES
ADMINISTRATION
[OMB Control No. 3090–0118; Docket No.
2020–0001; Sequence No. 4]

Information Collection; Federal
Management Regulation; Standard
Form 94, Statement of Witness
Office of Government-Wide
Policy (OGP), General Services
Administration (GSA).
ACTION: Notice; request for comments.
AGENCY:

Under the provisions of the
Paperwork Reduction Act, the
Regulatory Secretariat Division will be
submitting to the Office of Management
and Budget (OMB) a request to review
and approve an existing information
collection requirement regarding OMB
Control No: 3090–0118; Standard Form
94, Statement of Witness.
DATES: Submit comments on or before
August 3, 2020.
ADDRESSES: Submit comments
identified by Information Collection
3090–0118; Standard Form 94,
Statement of Witness via http://
www.regulations.gov. Submit comments
via the Federal eRulemaking portal by
searching for ‘‘Information Collection
3090–0118; Standard Form 94,
Statement of Witness’’. Select the link
‘‘Submit a Comment’’ that corresponds
with ‘‘Information Collection 3090–
0118; Standard Form 94, Statement of
Witness.’’ Follow the instructions
provided at the ‘‘Submit a Comment’’
screen. Please include your name,
company name (if any), and

lotter on DSK9F5VC42PROD with NOTICES

SUMMARY:

VerDate Sep<11>2014

18:21 Jun 04, 2020

Jkt 250001

‘‘Information Collection 3090–0118;
Standard Form 94, Statement of
Witness’’ on your attached document. If
your comment cannot be submitted
using https://www.regulations.gov, call
or email the points of contact in the FOR
FURTHER INFORMATION CONTACT section of
this document for alternate instructions.
Instructions: Please submit comments
only and cite Information Collection
3090–0118; Standard Form 94,
Statement of Witness, in all
correspondence related to this
collection. Comments received generally
will be posted without change to http://
www.regulations.gov, including any
personal and/or business confidential
information provided. To confirm
receipt of your comment(s), please
check www.regulations.gov,
approximately two-to-three days after
submission to verify posting.
FOR FURTHER INFORMATION CONTACT: Mr.
Ray Wynter, GSA, Office of
Government-wide Policy (MAG), Office
of Asset and Transportation
Management, at telephone 202–501–
3802 or via email to [email protected].
SUPPLEMENTARY INFORMATION:
A. Purpose
GSA’s Office of Government-wide
Policy is announcing the availability of
Standard Form 94, Statement of Witness
that is publicly available on http://
www.gsa.gov/forms. This updated
Standard Form 94, Statement of Witness
is a renewal of a currently approved
information collection requirement
regarding statement from witnesses.
This form will be used to collect
information from witnesses reporting
accidents and/or damage to Federal
Fleet Vehicles.
B. Annual Reporting Burden
Respondents: 290.
Responses per Respondent: 1.
Total Annual Responses: 290.
Hours per Response: 0.333.
Total Burden Hours: 97.
C. Public Comments
Public comments are particularly
invited on: Whether this collection of
information is necessary, whether it will
have practical utility; whether our
estimate of the public burden of this
collection of information is accurate,
and based on valid assumptions and
methodology; ways to enhance the
quality, utility, and clarity of the
information to be collected; and ways in
which we can minimize the burden of
the collection of information on those
who are to respond, through the use of
appropriate technological collection
techniques or other forms of information
technology.

PO 00000

Frm 00043

Fmt 4703

Sfmt 4703

34631

Obtaining Copies of Proposals:
Requesters may obtain a copy of the
information collection documents from
the Regulatory Secretariat Division, at
[email protected]. Please cite OMB
Control No. 3090–0118, Standard Form
94, Statement of Witness, in all
correspondence.
Beth Anne Killoran,
Deputy Chief Information Officer.
[FR Doc. 2020–12181 Filed 6–4–20; 8:45 am]
BILLING CODE 6820–14–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–20–1074; Docket No. CDC–2020–
0064]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Colorectal Cancer Control Program
(CRCCP) Monitoring Activities. CDC is
requesting a revision to OMB No. 0920–
1074 to include a redesigned survey, a
redesigned clinic-level data collection
instrument, and a new quarterly
awardee-level program update survey.
DATES: CDC must receive written
comments on or before August 4, 2020.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2020–
0064 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
SUMMARY:

E:\FR\FM\05JNN1.SGM

05JNN1

34632

Federal Register / Vol. 85, No. 109 / Friday, June 5, 2020 / Notices

Please note: Submit all comments through
the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.

To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7118; Email: [email protected].

FOR FURTHER INFORMATION CONTACT:

lotter on DSK9F5VC42PROD with NOTICES

SUPPLEMENTARY INFORMATION:

Under the Paperwork Reduction Act
of 1995 (PRA) (44 U.S.C. 3501–3520),
Federal agencies must obtain approval
from the Office of Management and
Budget (OMB) for each collection of
information they conduct or sponsor. In
addition, the PRA also requires Federal
agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each new proposed
collection, each proposed extension of
existing collection of information, and
each reinstatement of previously
approved information collection before
submitting the collection to the OMB for
approval. To comply with this
requirement, we are publishing this
notice of a proposed data collection as
described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.

VerDate Sep<11>2014

18:21 Jun 04, 2020

Jkt 250001

Proposed Project
Colorectal Cancer Control Program
(CRCCP) Monitoring Activities (OMB
Control No. 0920–1074, Exp. 7/31/
2020)—Revision—National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC)
Background and Brief Description
CDC is requesting a revision to
Colorectal Cancer Control Program
(CRCCP) Monitoring Activities (OMB
Control No. 0920–1074). Based on
feedback from awardees and internal
subject matter experts, CDC proposes
use of a revised annual grantee survey
instrument (renamed, Annual Awardee
Survey), a revised clinic-level data
collection instrument, and a new
awardee-level quarterly program update.
The number of respondents will also
increase from 30 to 35 awardees. Total
estimated annualized burden will
increase. OMB approval is requested for
three years.
Colorectal cancer (CRC) is the second
leading cause of death from cancer in
the United States among cancers that
affect both men and women. There is
substantial evidence that CRC screening
reduces the incidence of and death from
the disease. Screening for CRC can
detect disease early when treatment is
more effective, and prevent cancer by
finding and removing precancerous
polyps. Of individuals diagnosed with
early stage CRC, more than 90% live
five or more years. Despite strong
evidence supporting screening, only
68.8% of adults currently report being
up-to-date with CRC screening as
recommended by the U.S. Preventive
Services Task Force, with more than 22
million age-eligible adults estimated to
be untested. To reduce CRC morbidity,
mortality, and associated costs, use of
CRC screening tests must be increased
among age-eligible adults with the
lowest CRC screening rates.
The purpose of the Colorectal Cancer
Control Program (CRCCP) is to partner
with health systems and their
individual primary care clinics to
implement EBIs to increase CRC
screening among defined populations of
adults ages 50–75 that have CRC
screening rates lower than the national,
regional, or local rate. The previous
cooperative agreement supporting the
CRCCP (DP15–1502) funded 30
awardees that are state governments or
bona-fide agents, universities, and tribal
organizations. All 30 recipients received
Component 1 funding, which required
recipients to partner with health
systems and their primary care clinics to
implement at least two of four priority

PO 00000

Frm 00044

Fmt 4703

Sfmt 4703

evidence-based interventions (EBIs)
described in The Guide to Community
Preventive Services as well as other
supporting strategies. In addition, six
recipients received Component 2
funding to provide clinical screening
and follow-up services for a limited
number of individuals aged 50–64 in the
program’s priority population who are
asymptomatic, at average risk for CRC,
have inadequate or no health insurance
for CRC screening, and are low income.
In 2020, CDC issued a new funding
opportunity, Public Health and Health
System Partnerships to Increase
Colorectal Cancer Screening in Clinical
Settings (DP20–2002), a five-year
cooperative agreement to increase CRC
screening among defined populations of
adults ages 50–75 that have CRC
screening rates lower than the national,
regional, or local rate. Similar to DP15–
1502, DP20–2002 funds recipients to
partner with health systems and their
primary care clinics to implement
multiple EBIs, partner with
organizations to support
implementation of EBIs in those clinics,
and collect high-quality clinic-level data
when a clinic is recruited to participate
(baseline) and annually thereafter to
monitor EBI implementation and assess
screening rate changes. DP20–2002
eliminates Component 2 funding to
provide direct clinical service delivery.
However, DP20–2002 requires
recipients to conduct a formal capacity/
readiness assessment of potential clinics
to implement EBIs, use assessment
findings to select appropriate EBIs for
implementation, and provide clinics
with limited financial resources to
support follow-up colonoscopies for
under- and uninsured patients after an
abnormal CRC screening test.
CDC proposes three information
collections—a revised Annual Awardee
Survey, a revised Clinic-Level Data
Collection Instrument, and a new
awardee-level Quarterly Program
Update—to reflect the strategies and
objectives detailed in DP20–2002.
The previous Annual Awardee Survey
assessed: (1) Program management, (2)
health information technology, (3)
partnerships, (4) data use, (5) training
and technical assistance (TA), (6) clinic
service delivery. The revised instrument
no longer includes questions related to
clinic service delivery since these
pertained solely to Component 2, which
is no longer funded under DP20–2002.
In addition, many program management
questions were eliminated and will now
be gathered via the Quarterly Program
Update on a quarterly basis to better
inform CDC TA. Several data use
questions were eliminated as they did
not yield meaningful data to inform

E:\FR\FM\05JNN1.SGM

05JNN1

34633

Federal Register / Vol. 85, No. 109 / Friday, June 5, 2020 / Notices
CDC TA during the previous funding
cycle.
The previous Clinic-level Data
Collection instrument assessed: (1)
Health system and clinic characteristics,
(2) EBI and supporting activities
implementation within clinics; (3)
monitoring and quality improvement
activities, and (4)CRC screening rates.
The revised instrument was reorganized
(e.g., sections merged, variables moved
to new sections) for increased efficiency
and to improve overall data quality. In
addition, wording and responses for
many variables and their response
options have undergone minor revisions
to better capture awardees’ partnerships
with both health systems and clinics,
and appropriate capture of baseline and
annual variables. The revised

Redesigned data elements will enable
CDC to better gauge progress in meeting
CRCCP program goals and monitor
implementation activities, evaluate
outcomes, and identify awardee TA
needs. In addition, data collected will
inform program improvement and help
identify successful activities that need
to be maintained, replicated, or
expanded.
OMB approval is requested for three
years. The number of awardees will
increase from 30 awardees in DP15–
1502 to 35 awardees in DP20–2002, and
the number of clinic partners is
expected to increase from 12 to 24 per
awardee. Therefore, the total estimated
annualized burden hours have increased
from 204 to 663 hours.

instrument gathers information to assess
health system and clinic characteristics;
program reach; CRC screening practices
and outcomes; clinics’ quality
improvement and monitoring activities;
EBI implementation, and additional
factors that affect EBI implementation
over time.
The new Quarterly Program Update
will collect standardized awardee-level
information on aspects of program
management, including (1) quarterly
program expenditures, (2) current staff
vacancies, (3) program successes and
challenges, and (4) current TA needs.
This information collection will provide
CDC staff rapid reporting of
programmatic information to inform
their efforts to provide awardees with
tailored TA.

ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hr)

Total burden
(in hr)

Form name

CRCCP Awardees .........

CRCCP Annual Awardee Survey ........................
CRCCP Clinic-level Information Collection Instrument.
CRCCP Quarterly Program Update ....................

35
35

1
24

15/60
43/60

9
602

35

4

22/60

52

..............................................................................

........................

........................

........................

663

Total ........................

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–12244 Filed 6–4–20; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–20–20OS; Docket No. CDC–2020–
0062]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.

SUMMARY:

lotter on DSK9F5VC42PROD with NOTICES

Number of
responses per
respondent

Number of
respondents

Type of respondent

VerDate Sep<11>2014

18:21 Jun 04, 2020

Jkt 250001

This notice invites comment on a
proposed information collection project
titled COVID–19 Pandemic Response,
Laboratory Data Reporting. The
collection will be used to gather
comprehensive laboratory testing data to
ensure a rapid and thorough federal
response to the COVID–19 pandemic.
DATES: CDC must receive written
comments on or before August 4, 2020.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2020–
0062 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments through
the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.

To
request more information on the
proposed project or to obtain a copy of

FOR FURTHER INFORMATION CONTACT:

PO 00000

Frm 00045

Fmt 4703

Sfmt 4703

the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: [email protected].
Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including

SUPPLEMENTARY INFORMATION:

E:\FR\FM\05JNN1.SGM

05JNN1